MJP
Michael J. Puzo Portfolio holdings
AUM
$351M
1-Year Return
12.34%
This Quarter Return
+10.53%
1 Year Return
+12.34%
3 Year Return
+65.3%
5 Year Return
+106.55%
10 Year Return
+254.06%
AUM
$354M
AUM Growth
+$38.6M
(+12%)
Cap. Flow
+$5.55M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
39.17%
Holding
82
New
7
Increased
31
Reduced
24
Closed
–
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$851K |
| 2 |
Aptiv
APTV
|
$840K |
| 3 |
TJX Companies
TJX
|
$472K |
| 4 |
Nike
NKE
|
$424K |
| 5 |
NVIDIA
NVDA
|
$348K |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$548K |
| 2 |
Novartis
NVS
|
$300K |
| 3 |
3M
MMM
|
$287K |
| 4 |
Danaher
DHR
|
$269K |
| 5 |
Bank OZK
OZK
|
$234K |
Sector Composition
| 1 | Healthcare | 24.12% |
| 2 | Technology | 20.72% |
| 3 | Industrials | 12.19% |
| 4 | Financials | 7.78% |
| 5 | Consumer Discretionary | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Unilever
UL
$158B
| $5.57M | 1.57% |
103,474
+3,270
| +3% | +$176K |
|
|
27
TJX Companies
TJX
$157B
| $5.46M | 1.54% |
71,914
+6,222
| +9% | +$472K |
|
28
Chevron
CVX
$320B
| $5.38M | 1.52% |
45,795
+420
| +0.9% | +$49.3K |
|
|
29
Nike
NKE
$111B
| $5.1M | 1.44% |
30,618
+2,543
| +9% | +$424K |
|
30
Intel
INTC
$107B
| $4.79M | 1.35% |
93,075
-4,210
| -4% | -$217K |
|
31
PayPal
PYPL
$65.2B
| $4.2M | 1.18% |
22,242
+1,376
| +7% | +$260K |
|
32
Illumina
ILMN
$15.3B
| $3.89M | 1.1% |
10,498
+465
| +5% | +$172K |
|
33
PepsiCo
PEP
$201B
| $3.45M | 0.97% |
19,861
-118
| -0.6% | -$20.5K |
|
34
Honeywell
HON
$136B
| $3.01M | 0.85% |
14,436
+1,244
| +9% | +$259K |
|
35
Exxon Mobil
XOM
$481B
| $2.56M | 0.72% |
41,910
+135
| +0.3% | +$8.26K |
|
36
AbbVie
ABBV
$375B
| $1.91M | 0.54% |
14,103
+1,143
| +9% | +$155K |
|
37
McCormick & Company Non-Voting
MKC
$18.8B
| $1.89M | 0.53% |
19,550
| – | – |
|
38
Merck
MRK
$209B
| $1.84M | 0.52% |
24,000
| – | – |
|
39
Emerson Electric
EMR
$74.3B
| $1.53M | 0.43% |
16,477
-250
| -1% | -$23.2K |
|
|
40
Bank OZK
OZK
$5.96B
| $1.31M | 0.37% |
28,225
-5,020
| -15% | -$234K |
|
41
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.05M | 0.3% |
3,500
-500
| -13% | -$150K |
|
42
Union Pacific
UNP
$132B
| $945K | 0.27% |
3,750
| – | – |
|
43
Caterpillar
CAT
$196B
| $925K | 0.26% |
4,475
+400
| +10% | +$82.7K |
|
|
44
Edwards Lifesciences
EW
$47.4B
| $851K | 0.24% |
+6,570
| New | +$851K |
|
45
Visa
V
$683B
| $848K | 0.24% |
3,915
-380
| -9% | -$82.3K |
|
|
46
Aptiv
APTV
$17.4B
| $840K | 0.24% |
+5,096
| New | +$840K |
|
47
Deere & Co
DE
$126B
| $832K | 0.24% |
2,425
| – | – |
|
48
Pfizer
PFE
$139B
| $827K | 0.23% |
13,996
| – | – |
|
49
Eli Lilly
LLY
$669B
| $760K | 0.21% |
2,750
-162
| -6% | -$44.8K |
|
50
Novo Nordisk
NVO
$251B
| $694K | 0.2% |
12,400
+2,200
| +22% | +$123K |
|